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Abstract
Background: Little is known about long-term adverse health consequences experienced by flight
attendants exposed to secondhand smoke (SHS) during the time smoking was allowed on airplanes.
We undertook this study to evaluate the association between accumulated flight time in smoky
airplane cabins and respiratory tract diseases in a cohort of never smoking flight attendants.
Methods: We conducted a mailed survey in a cohort of flight attendants. Of 15,000 mailed
questionnaires, 2053 (14%) were completed and returned. We excluded respondents with a
personal history of smoking (n = 748) and non smokers with a history of respiratory tract diseases
before the age of 18 years (n = 298). The remaining 1007 respondents form the study sample.
Results: The overall study sample was predominantly white (86%) and female (89%), with a mean
age of 54 years. Overall, 69.7% of the respondents were diagnosed with at least one respiratory
tract disease. Among these respondents, 43.4% reported a diagnosis of sinusitis, 40.3% allergies,
30.8% bronchitis, 23.2% middle ear infections, 13.6% asthma, 13.4% hay fever, 12.5% pneumonia,
and 2.0% chronic obstructive pulmonary disease. More hours in a smoky cabin were observed to
be significantly associated with sinusitis (OR = 1.21; p = 0.024), middle ear infections (OR = 1.30;
p = 0.006), and asthma (OR = 1.26; p = 0.042).
Conclusion: We observed a significant association between hours of smoky cabin exposure and
self-reported reported sinusitis, middle ear infections, and asthma. Our findings suggest a dose-
response between duration of SHS exposure and diseases of the respiratory tract. Our findings add
additional evidence to the growing body of knowledge supporting the need for widespread
implementation of clean indoor air policies to decrease the risk of adverse health consequences
experienced by never smokers exposed to SHS.
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According to United States Surgeon General's Report,
available evidence suggests a causal relationship between
secondhand smoke (SHS) exposure and tobacco-related
diseases [1]. In healthy adults, SHS is associated with
upper and lower respiratory tract diseases and an
increased risk of asthma and chronic obstructive pulmo-
nary disease (i.e., bronchitis and emphysema). Among
lifetime nonsmokers, SHS is also associated with an
increased risk of lung cancer and death and disability
from coronary heart disease (CHD). Pooled analyses sug-
gest an overall 20–30% increase in the risk of lung cancer
and CHD attributable to SHS.
Prior to 1999, by which time 97% of flights to and from
the United States were smoke-free, flight attendants (FAs)
experienced 6 to 7 times the SHS exposure of ground-
based workers and 14 times that of the average person [2].
Based upon surveys conducted of general flight experi-
ences, FAs experienced a variety of physical symptoms
ranging from respiratory complaints to fatigue which may
have been attributable to a variety of in-flight factors in
addition to SHS before the airlines became smoke-free
[3]. However, in a study conducted before and after in-
flight smoking was eliminated, a causal link was estab-
lished between SHS and ocular symptoms, decreased tear-
film stability, and alterations in nasal patency [4]. Less is
known about the potential long-term health conse-
quences experienced by FAs exposed to SHS during the
time smoking was allowed on airplanes.
A number of studies have obtained FA personal health
histories in order to assess the health and comfort of FAs
in airliner cabins [3]. Most of these have focused on short-
term effects and respiratory symptoms, but also included
a mixture of flight attendants who were smokers and non
smokers. None of the published studies have evaluated
the association between the accumulated flying time and
diseases of the respiratory tract. We undertook the present
study to evaluate the association between accumulated
flight time prior to the airlines becoming smoke-free and




We developed a 26-item, self-administered mailed ques-
tionnaire. Items on the survey ascertained demographics,
smoking history, personal and family medical history,
exposure to toxic chemicals, alcohol consumption, and
duration of exposure to an airline cabin prior to institu-
tion of smoke-free airlines. All items were direct and face-
valid as determined by the investigators and structured
based upon previous population surveys [5]. We con-
ducted readability and usability testing of the survey on a
sample of 30 volunteers who were active or retired FAs.
The volunteers were recruited by mail. Feedback by these
volunteers on the survey was provided to investigators in
the written form which was collated and incorporated
into the final survey.
Survey sample
The study was reviewed and approved by the Mayo Insti-
tutional Review Board (IRB) and informed consent was
obtained from all participants. Subjects were identified
from a member database maintained by the Association
of Flight Attendants (AFA). Current and past flight attend-
ants (FAs) with pre-1987 seniority were selected to be sur-
veyed. The AFA did not have permission from its members
to provide a mailing list with their identifiers to an outside
organization, thus, the initial contact with potential sub-
jects was made through the AFA mailing house. No iden-
tifiable information was provided to the Mayo
investigators prior to the subjects signing informed con-
sent and completing the survey.
Survey procedure
In January 2005, approximately 15,000 surveys were
mailed from the AFA mailing house following the mailing
of an introductory letter. The introductory letter was from
the president of the AFA. This letter explained the back-
ground of the study, the collaboration between AFA and
Mayo Clinic, and encouragement to participate. The letter
informed members of the cohort that this study would
examine the association between SHS and adverse health
outcomes but not specifically about respiratory tract dis-
eases. The second mailing included more detail about the
study, the survey, and a consent form. In order to protect
confidentiality, surveys were mailed by the AFA mailing
house using the AFA mailing house identifier on the enve-
lope. Completed surveys were mailed back to the Mayo
Clinic Survey Research Center for verification of consent
and data entry. A single mailing was conducted with no
follow-up calls.
Survey items
Medical diagnoses were assessed by asking if respondents
"have ever taken medication for, had surgery for, or been
told by a doctor" that they have the condition of interest.
If respondents indicated affirmatively, they were asked to
indicate the age at which they were diagnosed with the
condition.
Response rate
Of the 15,000 questionnaires provided to the AFA mailing
house, 2053 (14%) were completed and returned to the
Mayo Clinic Survey Research Center. Information on the
number of undeliverable survey packets due to incorrect
or outdated address information was unavailable.Page 2 of 8
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to SHS increased the risk for the development of respira-
tory tract disease. Therefore, we excluded respondents
who had a personal history of smoking (n = 748) or non
smokers with a history of respiratory tract disease before
the age of 18 years (n = 298). The remaining 1007
respondents were never smokers with no reported respira-
tory tract disease prior to the age of 18 years and formed
the study sample for the current report.
Statistical methods
As part of the survey, respondents recorded information
regarding the number of hours they spent flying during
the time that smoking was allowed in airplane cabins.
Since mandated smoke-free policies changed over time
and some carriers adopted voluntary smoke-free policies
prior to these dates, respondents recorded information
separately for each carrier (i.e., company) for which they
worked during the time that smoking was allowed. Using
these data, the cumulative number of hours spent flying in
a smoky cabin was calculated for each respondent.
Logistic regression analyses were performed to assess
whether the diagnosis of disease after the age of 18 was
associated with the duration of time spent in a smoky
cabin. For these analyses, the duration of time spent in a
smoky cabin was analyzed as both a continuous variable
and also as a categorical variable with categories defined
using quartiles of the observed distribution (≤11,030
hours; 11,031 to 18,240 hours; 18,241 to 27,750 hours;
and ≥27,751 hours). The respondent's age at the time the
survey was included as a covariate in all models. Since
respondent age was missing for approximately 5% of the
study sample, the logistic regression analyses were per-
formed using a multiple imputation approach (10
imputed datasets constructed using Markov Chain Monte
Carlo method) with parameter estimates adjusted using
Rubin's rules [6]. Analyses were also performed using the
subset of respondents with complete data to ensure that
findings were consistent.
Separate analyses were performed for each disease of
interest. Findings from the logistic regression analyses are
summarized using odds ratios (ORs) and corresponding
95% confidence intervals (CIs). For the analysis with time
spent in the smoky cabin treated as a categorical variable,
the ORs are calculated using the lower quartile group as
the reference group. For the analysis with time spent in the
smoky cabin treated as a continuous variable, the OR was
calculated for an increase of 16,720 hours which corre-
sponded to the difference between the 25th and 75th per-
centile of the observed distribution. Respondent
characteristics (e.g. age, gender, race) were compared
across quartile groups using the Kruskall-Wallis test for
continuous variables and the chi-square test for categori-
cal variables. All analyses were performed using SAS (ver-
sion 8.2; SAS Institute, Inc, Cary, NC). In all cases, two-




The overall study sample was predominantly white (86%)
and female (89%), with a mean (SD) age of 53.5 (6.2)
years (Table 1). The median [interquartile range (IQR)]
number of hours spent in a smoky cabin was 18,240
(11,030 to 27,750) hours. Comparing across quartile
groups defined based on the distribution of time spent in
a smoky cabin, significant differences were found with
respect to age at time of the survey (p < 0.001), age at the
time of first job with any airline (p < 0.001), and gender
(p = 0.017). In all cases, the direction of the observed dif-
ferences was consistent with what would be expected for
this study population. Specifically, respondents who
reported more time in the smoky cabin tended to be older
at the time of the survey, younger when they started work-
ing for the airline industry, and female.
Frequency of respiratory tract disease and association with 
time spent in smoky cabin
Overall, 69.7% of the respondents reported being diag-
nosed with at least one respiratory tract disease after the
age of 18 years. The overall frequency of diagnosis after
the age of 18 for the individual diseases of interest
included: sinusitis (43.4%), allergies (40.3%), bronchitis
(30.8%), middle ear infections (23.2%), asthma (13.6%),
hay fever (13.4%), pneumonia (12.5%), and chronic
obstructive pulmonary disease (2.0%) (Table 2).
When time spent in a smoky cabin is treated as a continu-
ous variable, more hours in the smoky cabin was found to
be significantly associated with sinusitis (OR = 1.21, p =
0.024), middle ear infections (OR = 1.30, p = 0.006), and
asthma (OR = 1.26, p = 0.042) (Table 3 & Figure 1).
Time spent in a smoky cabin was also analyzed categori-
cally using quartiles of the observed distribution. With the
lowest quartile as the reference group, the diagnosis of any
respiratory tract disease was increased for those in the 4th
quartile (OR = 1.62, p = 0.025), sinusitis was increased for
both the 3rd (OR = 1.50, p = 0.032) and 4th(OR = 1.47, p
= 0.048) quartiles, and middle ear infection was increased
for both the 3rd (OR = 2.08, p = 0.001) and 4th (OR = 2.22,
p < 0.001) quartiles (Table 3).
Discussion
We observed a significant association between total hours
of smoky cabin exposure and reported sinusitis and mid-
dle ear infections among never smoking FAs who worked
in the airline industry when smoking was allowed on air-Page 3 of 8
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of the development of asthma among FAs with increased
exposure to smoky airplane cabins.
Previous surveys of cabin crews have consistently shown
high rates of upper airway symptoms but have been
focused on short-term effects [3]. SHS has been observed
to be independently, positively associated with respira-
tory tract symptoms such as sneezing, sore throat, and
cough [7] as well as nasal rhinitis [8]. The association of
SHS exposure and sinusitis has not been extensively stud-
ied in adults and most of the evidence concerning the
association of SHS with middle ear infections comes from
the pediatric literature [1]. However, a pathophysiologic
basis for causality exists as SHS causes inflammation in
the nasal mucosa, and non smokers may have a height-
ened sensitivity to SHS exposure [9]. Unfortunately and
expectedly, research on the adverse health consequences
associated with SHS exposure has been hindered by
tobacco industry tactics to undermine United States regu-
latory agencies [10].
Table 2: Frequency of respiratory tract diseases in flight attendants exposed to secondhand smoke
Quartiles of Total Hours Spent in Smoky Cabin
Respiratory Disease Overall, N = 1007
n (%)
Q1, N = 252
n (%)
Q2, N = 257
n (%)
Q3, N = 246
n (%)




702 (69.7) 167 (66.3) 173 (67.3) 168 (68.0) 194 (77.3)
Sinusitis 437 (43.4) 103 (40.9) 105 (40.9) 116 (47.0) 113 (45.0)
Allergies 406 (40.3) 100 (39.7) 98 (38.1) 106 (42.9) 102 (40.6)
Bronchitis 310 (30.8) 61 (24.2) 83 (32.3) 82 (33.2) 84 (33.5)
Middle Ear Infections 234 (23.2) 43 (17.1) 48 (18.7) 70 (28.3) 73 (29.1)
Asthma 137 (13.6) 25 (9.9) 32 (12.5) 40 (16.2) 40 (15.9)
Hay Fever 135 (13.4) 29 (11.5) 40 (15.6) 37 (15.0) 29 (11.6)
Pneumonia 126 (12.5) 24 (9.5) 26 (10.1) 34 (13.8) 42 (16.7)
COPD 20 (2.0) 4 (1.6) 4 (1.6) 5 (2.0) 7 (2.8)
Table 1: Characteristics of respondents in a survey of flight attendants and secondhand smoke exposure
Quartiles of Total Hours Spent in a 
Smoky Cabin
Quartiles of Total Hours Spent in a Smoky Cabin
Characteristic Overall (N = 1007) Q1 (n = 252) Q2 (n = 257) Q3 (n = 246) Q4 (n = 252)
Age at time of survey, years
mean (SD) 53.5 (6.2) 50.3 (6.6) 52.7 (5.8) 54.8 (5.2) 56.6 (5.2)
median (IQR) 54 (49 – 58) 49 (45 – 55) 54 (48 – 57) 55 (51 – 59) 57 (54 – 60)
Age at time of first airline job, years
mean (SD) 22.7 (3.4) 23.8 (3.7) 22.6 (2.8) 22.5 (3.3) 21.8 (3.3)
median (IQR) 22 (20 – 24) 23 (21 – 25) 22 (21 – 24) 22 (20 – 23.5) 21 (20 – 23)
Total hours spent in smoky cabin, hr
mean (SD) 20293 (13,219) 5946 (2,929) 14812 (1,996) 22782 (2,634) 37802 (11,466)











Male 110 (11) 38 (15.2) 30 (11.7) 26 (10.6) 16 (6.4)
Female 893 (89) 212 (84.8) 226 (88.3) 220 (89.4) 235 (93.6)
Race, n (%)
American Indian/Alaska Native 5 (0.5) 1 (0.4) 0(0) 2 (0.8) 2 (0.8)
Asian 38 (3.9) 12 (4.9) 8 (3.2) 9 (3.7) 9 (3.7)
Native Hawaiian/Pacific Islander 6 (0.6) 2 (0.8) 2 (0.8) 1 (0.4) 1 (0.4)
Black or African American 46 (4.7) 10 (21.7) 14 (5.5) 14 (5.8) 8 (3.3)
White 851 (86.2) 212 (85.8) 218 (85.8) 202 (83.1) 219 (90.1)
Hispanic 33 (3.3) 9 (3.6) 9 (3.5) 13 (5.4) 2 (0.8)
Multiple/Other 8 (0.8) 1 (0.4) 3 (1.2) 2 (0.8) 2 (0.8)
SD = standard deviation; IQR = interquartile rangePage 4 of 8
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cabin exposure and asthma in our cohort of FAs, consist-
ent with previous literature. SHS exposure has been asso-
ciated with asthma in adults, and available data suggest
that workplace exposure may be more detrimental than
domestic exposure [11]. In a cross-sectional study of 2195
never smoking Italian women, SHS exposure from spouse
and work was significantly and positively associated with
an asthma diagnosis or symptoms (OR 1.50; 95% CI
1.09–2.08) [12]. In a cross-sectional study of 4197 never
smoking adults in Switzerland, SHS was significantly
associated with physician-diagnosed asthma (OR 1.39;
95% CI: 1.04–1.86) [13]. In a cross-sectional study of
6817 adult never smokers in Estonia, SHS exposure out-
side the home was associated with physician-diagnosed
asthma (OR 1.79; 95% CI: 1.02–3.16), and SHS outside
the home was strongly related to all respiratory symptoms
in a dose-response manner [14]. In a nested-case control
study of adult-onset asthma, an increased odds for the
development of asthma was associated with SHS (OR 2.4;
95%, CI 1.4–4.1) [15]. In a more recent cross-sectional
study of 73,605 adults in India, individuals exposed to
SHS were more likely to have a diagnosis of asthma com-
pared to non-exposed individuals (OR 1.22; 95% CI
1.08–1.38) [16]. In a prospective study of 3914 adult non
smokers, SHS was significantly associated with the devel-
opment of asthma over a 10-year period [relative risk (RR)
= 1.45; 95% CI: 1.21–1.75] [17]. The extant literature and
our study suggest a dose-response relationship between
SHS exposure and adult-onset asthma.
The main strength of our study was that the survey was
conducted in a large sample of FAs who were never smok-
ers with a median of greater than 18,000 hours of SHS
exposure in smoky cabins.
Our study has several limitations. First, the response rate
to our survey was 14%. Because we did not have access to
the mailing list, we did not have complete information
regarding the accuracy of the address information and,
therefore, could not determine the total population who
received the survey. We were also unable to perform the
standard survey methodology of second and third mail-
ings followed up by telephone calls which would have
increased our response rate. Nonetheless, our response
rate was similar to the 17% response rate of the only other
survey of FAs larger than ours (N = 3,412) [18]. While our
sample of flight attendants is the second largest reported
Association between total hours in a smoky airplane cabin and respiratory tract diseasesFigure 1
Association between total hours in a smoky airplane cabin and respiratory tract diseases. The values presented correspond to 
the age-adjusted odds ratio (OR) and corresponding 95% confidence interval. The OR is calculated for an increase of 16,720 
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smokers. Given the low response rate and partial blinding
to study hypotheses, we cannot rule-out a potential non
response bias whereby symptomatic individuals may have
been more likely to respond to the survey than asympto-
matic individuals. This bias would result in overestimat-
ing the prevalence of disease in this cohort. However,
under the assumption that this response bias was inde-
pendent of SHS exposure, the findings from the analyses
assessing the association between SHS exposure and dis-
ease would not be affected. Second, the potential for recall
bias exists which is an inherent limitation of self-reported
medical surveys. Third, the survey design did not allow us
to associate the timing of the exposure to the timing of the
diagnosis for the index disease. Finally, SHS exposure is
but one factor that may have contributed to our findings.
Airplane cabin supply air is known to be contaminated
with smoke and fumes containing pyrolyzed engine oil
and/or hydraulic fluid which has been documented to
cause respiratory complaints [19,20]. The air supply can
also contain ozone gas in-flight and deicing fluid and/or
exhaust fumes during ground operations [21-23]. Since
47 countries require that cabins be sprayed either in-flight
or prior to boarding, pesticide exposure is another possi-
ble exposure and has been associated with respiratory ill-
ness [24,25]. FAs have also been identified as more likely
to report infectious respiratory illnesses than the popula-
tion of ground-based working women [26]. Notably, the
per person ventilation rate in the aircraft is typically lower
than in comparable ground-based environments which
elevates bioeffluent levels and contaminants from cabin
cleaners/deodorizers/offgassing cabin materials [27].
Finally, reduced barometric pressure in-flight and regular
pressure changes may contribute to some respiratory con-
Table 3: Association of respiratory tract diseases with the duration of time spent in a smoky cabin*
Quartiles of Total Hours Spent in Smoky Cabin
Disease Overall Q1 Q2 Q3 Q4
Any respiratory disease
Odds Ratio 1.17 1.0 1.02 1.03 1.62†
(95% C. I.) (0.97, 1.42) (0.70, 1.49) (0.70, 1.52) (1.06, 2.48)
Sinusitis
Odds Ratio 1.21† 1.0 1.09 1.50† 1.47†
(95% C. I.) (1.03, 1.44) (0.76, 1.56) (1.04, 2.18) (1.00, 2.16)
Allergies
Odds Ratio 1.01 1.0 0.93 1.13 1.03
(95% C. I.) (0.85, 1.20) (0.65, 1.34) (0.78, 1.64) (0.70, 1.5)
Bronchitis
Odds Ratio 1.04 1.0 1.41 1.40 1.36
(95% C. I.) (0.87, 1.25) (0.95, 2.09) (0.93, 2.10) (0.89, 2.06)
Middle Ear Infections
Odds Ratio 1.30† 1.0 1.16 2.08† 2.22†
(95% C. I.) (1.08, 1.57) (0.74, 1.84) (1.33, 3.25) (1.40, 3.52)
Asthma
Odds Ratio 1.26† 1.0 1.20 1.54 1.43
(95% C. I.) (1.01, 1.57) (0.69, 2.11) (0.89, 2.67) (0.81, 2.52)
Hay Fever
Odds Ratio 0.92 1.0 1.35 1.24 0.89
(95% C. I.) (0.71, 1.18) (0.81, 2.27) (0.72, 2.13) (0.50, 1.59)
Pneumonia
Odds Ratio 1.09 1.0 1.02 1.40 1.71
(95% C. I.) (0.86, 1.39) (0.57, 1.85) (0.79, 2.48) (0.96, 3.03)
COPD
Odds Ratio 1.43 1.0 0.91 1.12 1.46
(95% C. I.) (0.89, 2.32) (0.22, 3.72) (0.29, 4.37) (0.39, 5.51)
* To assess whether the diagnosis of disease after the age of 18 years was associated with the duration of time spent in a smoky cabin a series of 
logistic regression analyses were performed. An overall analysis was performed with the duration of time spent in a smoky cabin analyzed as a 
continuous variable and a supplemental analysis was performed with duration of time spent in a smoky cabin analyzed as a categorical variable with 
categories defined using quartiles of the observed distribution (≤11030 hours, 11031 to 18240 hours, 18241 to 27750 hours, and ≥27751 hours). 
The respondent's age at the time the survey was included as a covariate in all models. Findings from the logistic regression analyses are summarized 
using odds ratios (ORs) and corresponding 95% confidence intervals (CIs). For the analysis with time spent in the smoky cabin treated as a 
continuous variable, the OR is calculated for an increase of 16,720 hours which corresponds to the difference between the 25th and 75th percentile 
of the observed distribution. For the analysis with time spent in the smoky cabin treated as a categorical variable, the ORs are calculated using the 
lower quartile group as the reference group. † p ≤ 0.05Page 6 of 8
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non smoking airline flights observed a marked reduction
in respirable particles and fewer symptoms such as ocular
complaints, headaches, and fatigue in non-smoking
flights [4]. This study would suggest that the elimination
of SHS, with all other factors remaining the same, has a
significant positive impact on the respiratory system.
Conclusion
Despite these weaknesses, our study adds to the body of
literature supporting a relationship between SHS and
adverse health consequences among non smokers. Our
data supports the need for continuing to implement clean
indoor air policies to protect non smokers from the harm-
ful effects of cigarette smoke.
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